Evotec AG: Evotec SE Fiscal Year 2021 Results: 'Setting the Pace' on the Data-Driven R&D Autobahn to Cures

STRONG FINANCIAL RESULTS: 23% INCREASE IN GROUP REVENUES SIGNIFICANTLY EXCEEDING GUIDANCEDATA-DRIVEN PLATFORMS AND TECHNOLOGIES INCREASE PROBABILITIES OF SUCCESS IN ALL MODALITIESSUBSTANTIALLY STRENGTHENED

Related Keywords

Germany ,Garonne ,France General ,France ,Eppendorf ,Nordrhein Westfalen ,Hamburg ,United States ,Munich ,Bayern ,United Kingdom ,Neuried ,Italy ,French ,Volker Braun ,Evotec Biologics ,Matthias Evers ,Bristol Myers Squibb ,Werner Lanthaler ,Gabriele Hansen ,Evotec Group ,Center Hamburg ,Linkedin ,Evotec Se Frankfurt Stock Exchange ,Nasdaq ,Head Of Global Corporate Communications Marketing ,Us Department Of Defense ,Exscientia Ltd ,Oxford University ,Frankfurt Stock Exchange ,Glaxosmithkline Spa ,Crowfoot Hodgkin ,Campus Neuried ,Chief Business Officer ,Chinook Therapeutics ,Medical Center Hamburg Eppendorf ,Kazia Therapeutics ,Danube Labs ,Eastern Europe ,Topas Therapeutics ,Bicycle Therapeutics ,Related Sciences ,Good Manufacturing Practice ,Occitanie Region ,Chief Executive Officer ,Global Corporate Communications ,Global Investor Relations ,Evotec ,Iscal ,Ear ,021 ,Results ,Setting ,Race ,Data ,Riven ,Autobahn ,Mures ,